Please assess the completion status of the following clinical trial:

Trial Title: Effect of Desipramine on Upper Airway Collapsibility and Genioglossus Muscle Activity in Patients With Obstructive Sleep Apnea - Study B

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed OSA (moderate-to-severe; apnea hypopnea index \>15 events/hr)~Exclusion Criteria:~* Cardiovascular disease other than well controlled hypertension~* Depression

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Desipramine First, Placebo Second (Type: ACTIVE_COMPARATOR): Desipramine 200 mg administered 2 hours before normal sleep time on first study night, then a 1-week non-treatment period, then placebo-matching desipramine administered 2 hours before normal sleep time on second study night.
- Placebo First, Desipramine Second (Type: EXPERIMENTAL): Placebo-matching desipramine administered 2 hours before normal sleep time on first study night, then a 1-week non-treatment period, then desipramine administered 2 hours before normal sleep time on second study night.

Based on this trial design, predict the completion outcome and termination type (if applicable).